Combination treatment of all-trans retinoic acid (ATRA) and Î³-secretase inhibitor (DAPT) cause growth inhibition and apoptosis induction in the human gastric cancer cell line.

Patrad, Elham; Niapour, Ali; Farassati, Faris; Amani, Mojtaba

Patrad, Elham; Niapour, Ali; Farassati, Faris; Amani, Mojtaba.

Affiliation

Patrad E; Department of Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Niapour A; Research Laboratory for Embryology and Stem Cells, Department of Anatomical Sciences, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. a.niapour@arums.ac.ir.
Farassati F; Molecular Medicine Laboratory, Department of Medicine, The University of Kansas Medical School (KUMC), Kansas City, KS, USA.
Amani M; Department of Biochemistry, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran. m.amani@arums.ac.ir.

Cytotechnology ; 70(2): 865-877, 2018 Apr.

Article de En | MEDLINE | ID: mdl-29417442

Mots clés

ATRA; Caspase 3/7; Combination therapy; DAPT; Gastric cancer; bcl-2

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Cytotechnology Sujet du journal: BIOTECNOLOGIA / GENETICA Année: 2018 Type de document: Article Pays d'affiliation: Iran Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google